Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Leukemia|March 28, 2013
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesM M Patnaik, E Padron, R R LaBorde, et al.
Leukemia|June 11, 2013
AKT is a therapeutic target in myeloproliferative neoplasmsI Khan, Z Huang, Q Wen, et al.
Leukemia|March 6, 2009
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisA Tefferi, A Pardanani, K-H Lim, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Leukemia|October 22, 2011
Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2A V Purandare, T M McDevitt, H Wan, et al.
Leukemia|April 27, 2013
Mutations and prognosis in primary myelofibrosisA M Vannucchi, T L Lasho, P Guglielmelli, et al.
Pageof 3